Anemia of malignancy

E. P. Frenkel, R. L. Bick, C. J. Rutherford

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Anemia is a common association of malignant disease. It may be the first diagnostic clue to an underlying malignant disease, it may contribute to the patient's symptoms from the disease, and it may affect treatment decisions. It is important to recognize that a number of underlying mechanisms may contribute to the anemia, and to exclude those that are treatable. The recognition that tumor-associated cytokine production is a major factor in the anemia of malignancy, and that recombinant EPO can overcome this suppression, are major steps forward.

Original languageEnglish (US)
Pages (from-to)861-874
Number of pages14
JournalHematology/Oncology Clinics of North America
Volume10
Issue number4
DOIs
StatePublished - Jan 1 1996

    Fingerprint

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this